Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the vivotif market grown in recent years?

In recent times, the vivotif market size has experienced a XX (HCAGR) increase. Forecasts suggest a growth from $XX million in 2024 to $XX million by 2025, delivering a compound annual growth rate (CAGR) of XX%. Several factors can account for this historical growth, including a surge in global travel, increased incidences of typhoid fever, a rise in urban development, broader access to healthcare facilities, and an increase in disposable income.

How is the vivotif market size expected to evolve during the forecast period?

Anticipations are made for the vivotif market size to witness a Compound Annual Growth Rate (CAGR) of XX% in the years to come, scaling up its value to $XX million by 2029. Factors such as a rise in awareness of vaccination’s benefits, a notable increase in typhoid fever cases, the convenience and effectiveness of orally administered vaccines, advancements in vaccine technology and uptick in research activities are contributing to the growth predicted for the forecast period. Some prevalent trends for the forecast period include an emerging preference for oral vaccines, a heightened focus on vaccines for travelers, the integration of vivotif within travel health kits, the evolution of combination vaccines, and a shift towards preventive healthcare.

Get your vivotif market report here!

https://www.thebusinessresearchcompany.com/report/vivotif-global-market-report

Which key drivers are propelling the vivotif market’s growth?

The growth of the vivotif market is forecasted to be driven by the rising instances of typhoid fever. Typhoid fever stems from a bacterial infection brought on by Salmonella Typhi, often spread through contaminated food or water, resulting in fever, abdominal discomfort, and fatigue. The increasing number of typhoid fever cases can be attributed to inadequate sanitation, poor accessibility to clean water, and escalating antibiotic resistance, particularly in low-income regions. Vivotif offers a solution by reducing the incidence of typhoid fever through a preventative oral vaccine against Salmonella Typhi, designed especially for areas with poor hygiene standards. For instance, data published by GOV.UK, a government platform based in the UK, in August 2024 shows that around 645 cases of typhoid fever were reported in 2023 across England, Wales, and Northern Ireland, up from 470 in 2022. This highlights a year-over-year increase in the disease’s occurrence, thereby fuelling the vivotif market’s expansion.

What are the market segments in the vivotif industry?

The vivotif market covered in this report is segmented –

1) By Clinical Indication: Typhoid; Other Indications

2) By Distribution Channel: Direct Sales; Online Pharmacies; Retail Pharmacies

3) By End-User: Adults; Pediatric

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20449&type=smp

Which leading companies are shaping the growth of the vivotif market?

Major companies operating in the vivotif market are Bavarian Nordic A/S

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20449

Which geographic areas are influencing the growth of the vivotif market?

Asia-Pacific was the largest region in the vivotif market in 2024. The regions covered in the vivotif market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Vaccine Adjuvants Global Market Report 2025

https://thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Conjugate Vaccine Global Market Report 2025

https://thebusinessresearchcompany.com/report/conjugate-vaccine-global-market-report

Cervical Cancer Vaccine Global Market Report 2025

https://thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: